Clinical Trial Update: Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial [NA]

View source ↗

Summary

The OPTIMIZE-ILD-1 trial aiming to optimize the diagnostic journey for interstitial lung disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrotic Interstitial Lung Disease
• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Interstitial Lung Disease Due to Connective Tissue Disease
• Suspected Interstitial Lung Disease

Snippet

Sponsor: Hospital de Granollers | Conditions: Interstitial Lung Disease (ILD), Suspected Interstitial Lung Disease | NA | Status: RECRUITING